FdaApplication
NDA 218475
Identifiers
- fda_app_no: NDA218475
Properties
| Property | Value |
|---|---|
| applicant_name | BAXTER HEALTHCARE CORP |
| application_type | NDA |
| approval_date | 2025-02-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EPINEPHRINE BITARTRATE | EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) | SOLUTION;INTRAVENOUS |
| EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | EPINEPHRINE BITARTRATE | EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) | SOLUTION;INTRAVENOUS |
2 products